GENTIAN DIAGNOSTICS ASA (GENT.OL) Fundamental Analysis & Valuation

OSL:GENT • NO0010748866

38.1 NOK
-1.4 (-3.54%)
Last: Mar 6, 2026, 03:59 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This GENT.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

GENT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. GENT has an excellent financial health rating, but there are some minor concerns on its profitability. GENT is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. GENT.OL Profitability Analysis

1.1 Basic Checks

  • GENT had positive earnings in the past year.
  • GENT had a positive operating cash flow in the past year.
  • In the past 5 years GENT reported 4 times negative net income.
  • In multiple years GENT reported negative operating cash flow during the last 5 years.
GENT.OL Yearly Net Income VS EBIT VS OCF VS FCFGENT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • GENT has a better Return On Assets (18.38%) than 96.83% of its industry peers.
  • GENT's Return On Equity of 21.18% is amongst the best of the industry. GENT outperforms 90.48% of its industry peers.
  • GENT has a better Return On Invested Capital (8.76%) than 73.02% of its industry peers.
Industry RankSector Rank
ROA 18.38%
ROE 21.18%
ROIC 8.76%
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
GENT.OL Yearly ROA, ROE, ROICGENT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • The Profit Margin of GENT (24.80%) is better than 95.24% of its industry peers.
  • With a decent Operating Margin value of 13.44%, GENT is doing good in the industry, outperforming 60.32% of the companies in the same industry.
  • The Gross Margin of GENT (55.06%) is comparable to the rest of the industry.
  • GENT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.44%
PM (TTM) 24.8%
GM 55.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
GENT.OL Yearly Profit, Operating, Gross MarginsGENT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. GENT.OL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GENT is still creating some value.
  • GENT has about the same amout of shares outstanding than it did 1 year ago.
  • GENT has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, GENT has an improved debt to assets ratio.
GENT.OL Yearly Shares OutstandingGENT.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
GENT.OL Yearly Total Debt VS Total AssetsGENT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 13.02 indicates that GENT is not in any danger for bankruptcy at the moment.
  • GENT has a Altman-Z score of 13.02. This is amongst the best in the industry. GENT outperforms 95.24% of its industry peers.
  • GENT has a debt to FCF ratio of 0.59. This is a very positive value and a sign of high solvency as it would only need 0.59 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.59, GENT belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
  • A Debt/Equity ratio of 0.01 indicates that GENT is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.01, GENT belongs to the top of the industry, outperforming 92.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.59
Altman-Z 13.02
ROIC/WACC1.03
WACC8.48%
GENT.OL Yearly LT Debt VS Equity VS FCFGENT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • GENT has a Current Ratio of 5.98. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
  • GENT's Current ratio of 5.98 is amongst the best of the industry. GENT outperforms 98.41% of its industry peers.
  • A Quick Ratio of 4.16 indicates that GENT has no problem at all paying its short term obligations.
  • GENT's Quick ratio of 4.16 is amongst the best of the industry. GENT outperforms 96.83% of its industry peers.
Industry RankSector Rank
Current Ratio 5.98
Quick Ratio 4.16
GENT.OL Yearly Current Assets VS Current LiabilitesGENT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. GENT.OL Growth Analysis

3.1 Past

  • GENT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2066.40%, which is quite impressive.
  • The Revenue has grown by 17.42% in the past year. This is quite good.
  • GENT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.96% yearly.
EPS 1Y (TTM)2066.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.54%
Revenue 1Y (TTM)17.42%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%27.94%

3.2 Future

  • The Earnings Per Share is expected to grow by 62.29% on average over the next years. This is a very strong growth
  • GENT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.47% yearly.
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year19.87%
Revenue Next 2Y19.6%
Revenue Next 3Y20.47%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
GENT.OL Yearly Revenue VS EstimatesGENT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
GENT.OL Yearly EPS VS EstimatesGENT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2 -2

More info and screens

Find the best growth stocksShow best growing peers

5

4. GENT.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 13.96, which indicates a correct valuation of GENT.
  • Compared to the rest of the industry, the Price/Earnings ratio of GENT indicates a rather cheap valuation: GENT is cheaper than 95.24% of the companies listed in the same industry.
  • GENT is valuated rather cheaply when we compare the Price/Earnings ratio to 26.69, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 14.04 indicates a correct valuation of GENT.
  • GENT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. GENT is cheaper than 77.78% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.79. GENT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.96
Fwd PE 14.04
GENT.OL Price Earnings VS Forward Price EarningsGENT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • GENT's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GENT indicates a slightly more expensive valuation: GENT is more expensive than 63.49% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 180.83
EV/EBITDA 16.27
GENT.OL Per share dataGENT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • GENT's earnings are expected to grow with 62.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y62.29%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. GENT.OL Dividend Analysis

5.1 Amount

  • GENT has a Yearly Dividend Yield of 1.49%.
  • The stock price of GENT dropped by -27.92% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 1.06, GENT pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, GENT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.49%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y62.29%
EPS Next 3YN/A
GENT.OL Yearly Income VS Free CF VS DividendGENT.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

More info and screens

Find the best dividend stocksShow peers with best dividend

GENT.OL Fundamentals: All Metrics, Ratios and Statistics

GENTIAN DIAGNOSTICS ASA

OSL:GENT (3/6/2026, 3:59:04 PM)

38.1

-1.4 (-3.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners39.37%
Inst Owner ChangeN/A
Ins Owners2.6%
Ins Owner ChangeN/A
Market Cap587.50M
Revenue(TTM)172.52M
Net Income(TTM)42.78M
Analysts85.71
Price Target64.26 (68.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.49%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.97%
PT rev (3m)-5.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-8.59%
Revenue NY rev (3m)-8.59%
Valuation
Industry RankSector Rank
PE 13.96
Fwd PE 14.04
P/S 3.41
P/FCF 180.83
P/OCF 47.38
P/B 2.91
P/tB 3.46
EV/EBITDA 16.27
EPS(TTM)2.73
EY7.17%
EPS(NY)2.71
Fwd EY7.12%
FCF(TTM)0.21
FCFY0.55%
OCF(TTM)0.8
OCFY2.11%
SpS11.19
BVpS13.1
TBVpS11.01
PEG (NY)0.23
PEG (5Y)N/A
Graham Number28.37
Profitability
Industry RankSector Rank
ROA 18.38%
ROE 21.18%
ROCE 11.37%
ROIC 8.76%
ROICexc 15.22%
ROICexgc 21.01%
OM 13.44%
PM (TTM) 24.8%
GM 55.06%
FCFM 1.88%
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.59
Debt/EBITDA 0.06
Cap/Depr 101.32%
Cap/Sales 5.3%
Interest Coverage 250
Cash Conversion 38.48%
Profit Quality 7.6%
Current Ratio 5.98
Quick Ratio 4.16
Altman-Z 13.02
F-Score5
WACC8.48%
ROIC/WACC1.03
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2066.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.54%
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.42%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%27.94%
Revenue Next Year19.87%
Revenue Next 2Y19.6%
Revenue Next 3Y20.47%
Revenue Next 5YN/A
EBIT growth 1Y260.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year169.23%
EBIT Next 3Y84.01%
EBIT Next 5Y65.28%
FCF growth 1Y127.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y285.08%
OCF growth 3YN/A
OCF growth 5YN/A

GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ

Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?

ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.


Can you provide the valuation status for GENTIAN DIAGNOSTICS ASA?

ChartMill assigns a valuation rating of 5 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.


Can you provide the profitability details for GENTIAN DIAGNOSTICS ASA?

GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.


How financially healthy is GENTIAN DIAGNOSTICS ASA?

The financial health rating of GENTIAN DIAGNOSTICS ASA (GENT.OL) is 9 / 10.


What is the earnings growth outlook for GENTIAN DIAGNOSTICS ASA?

The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 59.41% in the next year.